… target were predicted. This study will provide new lead compounds and targets for further in
vitro and in vivo studies of SARS-CoV-2, … drug repositioning to treat SARS-CoV-2 infections. …

… like SARS, MERS, and Ebola. This review presents a critical analysis of druggable targets
of SARS CoV-2, new drug discovery, development, and treatment opportunities for COVID-19. …

… COVID-19 convalescent patients, respectively. CD4 + T cell responses to spike, the main
target … and correlated with the magnitude of the anti-SARS-CoV-2 IgG and IgA titers. The M, …

… are crucial for binding to ACE2, five differ from SARS-CoV [27]. The similarity between S
protein of SARS-CoV-2, SARS CoV, and MERS CoV is that in all these it exists in homologous …

… in CoV-19 patients. To further our understanding of the mechanism and pathways of SARS-CoV-2
… -types and organ systems to SARS-CoV-2 attack in this communication we analyzed …

… respiratory syndrome-coronavirus 2 (SARS-CoV-2) represents … is compelling evidence that
novel SARS-CoV-2 is a highly … Like other coronaviruses, SARS-CoV-2 recognizes human …

… SARS-CoV-2 is a new strain of corona virus that has not been traced in humans previously.
In this review, we primarily focus on multiple features of SARS-CoV-2… molecular targets, …

… -driven entry into simian Vero target cells [16]. Sera from mice immunized with a stabilized
SARS-CoV S protein also significantly inhibited cell entry of SARS-CoV-2 into target cells [19], …

… In this study, we focus on the SARS-CoV-2 nucleocapsid protein as a suitable candidate
target for vaccine formulations. Major B and T cell epitopes of the SARS-CoV-2 N protein are …

… for SARS-CoV-1 and 34.4 % for MERS-CoV. More recently, the severe acute respiratory
syndrome coronavirus virus 2 (SARS-CoV-2… agent of the recent COVID-19 pandemic outbreak. It …